毛莉萍
查看科室更多醫(yī)生
出診信息
注：出診時間如有變化，以當(dāng)日掛號為準(zhǔn)| 門診時間 | 門診地點(diǎn) |
|---|---|
| 星期 一 (下午) | 慶春院區(qū) |
個人簡介
浙江大學(xué)醫(yī)學(xué)院附屬第一醫(yī)院副主任醫(yī)師
專業(yè)擅長
擅長急慢性白血病,，惡性淋巴瘤,，多發(fā)性骨髓瘤，骨髓增生異常綜合征等惡性血液病的診治及血小板減少和各類貧血的診治,。
研究方向
急性白血病的發(fā)病機(jī)制及新療法
成果獎項(xiàng)：（近五年主要成果及獎勵情況）
成果獎項(xiàng)：（近五年主要成果及獎勵情況）
1, Lou Y,Shao L,Mao L,Lu Y,Ma Y,Fan C,Jiang H,Li J,Jin J*.Efficacy and predictive factors of venetoclax combined with azacitidine as salvage therapy in advanced acute myeloid leukemia patients: A multicenter retrospective study. Leuk Res.2020 Feb 14;91:106317.
2,Mei C, Ren Y, Zhou X, Ye L, Ma L, Luo Y, Lin P, Xu W, Lu C, Yang H, Yu W,Mao L, Wei J, Jin J, Tong H*.Clinical and biological characteristics of acute myeloid leukemia with 20-29% blasts: a retrospective single-center study. Leuk Lymphoma. 2019 May;60(5):1136-1145.
3, Yu W, Guo Q, Wang Z, Mao L, Wei J, Jin J*, Wang J*, Clinical Significance of Prognostic Nutritional Index for Patients with Diffuse Large B-cell Lymphoma, Nutr Cancer, 2018: 1-6.doi: 10.1080/01635581.2018.1540718.
4, Li Y, Yang C, Mao L, Wang J, Li C, Qian W*, Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor, Medicine (Baltimore), 2017, 96(39): e8091
5, Wang J#, Guo Q#, Ma ZX, Ma QL, Yu MX, Yin XF, Lu SS, Xie HQ, Jiang YH, Shen D, Ma LY, Shi H, Yu WJ, Lou YJ, Li Y, Yang M, Xu GX, Mao L, Li JH, Wang HP, Wang DM, Wei JY*, Tong HY*, Huang J*, Jin J*, Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients, PLoS One, 2015, 10(10): e0140622
6.國家自然科學(xué)基金面上項(xiàng)目,，81470305，D/L-2-HG兩種對映異構(gòu)體在AML患者的預(yù)后意義及降低高水平2-HG的機(jī)制研究,，2015/01-2018/12,，70萬元，已結(jié)題,，參與,。
